Skip to main content
. 2018 Aug 28;8(4):521–528. doi: 10.1002/cpdd.608

Table 1.

Descriptive Statistics of Demographic Data for Subjects Included in the Pharmacokinetic Population

PK Population
Category Comparison (A/C), n = 34 Comparison (B/A), n = 32 Comparison (B/C), n = 31
Age (years) Mean ± SD 35 ± 9 36 ± 9 36 ± 9
Range 23–50 23–50 23–50
Median 35 35 35
BMI (kg/m2) Mean ± SD 24.62 ± 3.01 24.51 ± 3.11 24.35 ± 3.02
Range 19.54–29.93 19.54–29.93 19.54–29.93
Median 24.44 23.92 23.69
Height (cm) Mean ± SD 168.8 ± 7.8 168.6 ± 7.6 168.5 ± 7.6
Range 156.5–186.0 156.5–186.0 156.5–186.0
Median 166.3 166.3 165.5
Weight (kg) Mean ± SD 70.49 ± 12.27 70.02 ± 12.26 69.43 ± 11.98
Range 52.70–103.20 52.70–103.20 52.70–103.20
Median 71.10 70.50 70.50

PK, pharmacokinetic; n, number of observations; SD, standard deviation; BMI, body mass index.

A: levothyroxine sodium oral solution administered with water.

B: levothyroxine sodium oral solution administered without water.

C: levothyroxine sodium capsule.